Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Vaccine for Central Nervous System Cancer by Immunomic Therapeutics for Oligodendroglioma: Likelihood of Approval
Vaccine for Central Nervous System Cancer is under clinical development by Immunomic Therapeutics and currently in Phase I for Oligodendroglioma....
Data Insights
Vaccine for Central Nervous System Cancer by Immunomic Therapeutics for Anaplastic Astrocytoma: Likelihood of Approval
Vaccine for Central Nervous System Cancer is under clinical development by Immunomic Therapeutics and currently in Phase I for Anaplastic...